| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |